玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)230.027.786.541695.12519.23-1.57-157.38-20.774.49315.87219.10.913.9280.00.91-96.28135.14-0.36-227.27-2.861.511610.0639.29168.072149.63354.5168.172150.85364.3839.25878.22-58.02
23Q3 (19)230.027.78-0.4161.32-165.08-0.6141.3536.46-2.08-24.5511.110.7964.581.2824.46406.427.85-0.1160.7145.0-0.158.33-190.91-8.2086.07-149.76-8.2086.09-149.7622.97-6.224.01
23Q2 (18)234.5543.75-1.06-73.774.5-1.04-33.33-19.54-1.67-173.7746.820.48-18.64-31.434.83-78.6-76.8-0.28-55.56-40.0-0.24-84.62-33.33-58.85-157.89-133.25-58.97-158.41-133.73-0.32-6.433.34
23Q1 (17)2222.22-72.84-0.6160.9-48.78-0.7840.048.68-0.6183.82-48.780.5918.05.3622.57971.4374.15-0.1848.5748.57-0.1353.5760.61-22.8265.4560.82-22.8264.1360.82-8.95-143.362.29
22Q4 (16)180.0-75.34-1.56-347.62-403.23-1.30-35.42-11.11-3.77-61.11-190.00.5-35.961.29-2.59-111.4283.7-0.35-75.0-29.63-0.28-354.55-21.74-66.04-500.738.01-63.61-485.9811.39-12.23-95.43-22.88
22Q3 (15)1812.5-77.780.63156.76270.27-0.96-10.3428.89-2.3425.48-127.180.7811.43188.8922.688.93170.41-0.20.035.480.11161.11136.6716.48165.32115.1116.48165.32115.1118.21-6.9816.21
22Q2 (14)16-80.25-75.76-1.11-170.73-362.5-0.8742.76-24.29-3.14-665.85-383.080.725.0112.1220.8260.65-12.19-0.242.86-25.0-0.1845.45-12.5-25.2356.6947.31-25.2356.6947.3152.83-101.496.42
22Q1 (13)8110.9622.73-0.41-32.262.38-1.52-29.91-20.63-0.4168.462.380.5680.6580.6512.96181.56316.0-0.35-29.63-16.67-0.33-43.48-22.22-58.2518.8634.17-58.2518.8634.1747.73-8.02-8.29
21Q4 (12)73-9.8817.74-0.3116.2222.5-1.1713.3329.09-1.30-26.2130.480.3114.8124.0-15.8950.6751.36-0.2712.928.95-0.2323.338.0-71.7934.226.67-71.7934.226.67-1.68-18.98-39.77
21Q3 (11)8122.7322.73-0.37-54.17-2.78-1.35-92.86-19.47-1.03-58.4631.330.27-18.18-3.57-32.21-235.85-1253.36-0.31-93.75-14.81-0.3-87.5-30.43-109.10-127.86-31.81-109.10-127.86-31.83-5.87-5.66-24.21
21Q2 (10)660.00.0-0.2442.8656.36-0.7044.4457.58-0.65-54.7643.970.336.4522.2223.71495.17153.27-0.1646.6757.89-0.1640.7455.56-47.8845.8964.38-47.8845.8964.4315.2218.9334.04
21Q1 (9)666.4534.69-0.42-5.032.26-1.2623.6411.89-0.4277.5432.260.3124.047.62-6.0081.6350.41-0.321.056.25-0.27-8.012.9-88.489.6239.28-88.489.6239.286.64-8.05-11.19
20Q4 (8)62-6.0644.19-0.40-11.1172.22-1.65-46.02-5.1-1.87-24.6747.770.25-10.71-7.41-32.67-1272.69-342.08-0.38-40.74-2.7-0.25-8.759.02-97.90-18.2856.37-97.90-18.2956.37-3.5111.72-7.25
20Q3 (7)660.057.14-0.3634.5550.68-1.1331.5210.32-1.50-29.3129.910.283.7-50.88-2.3894.65-122.5-0.2728.953.57-0.2336.1125.81-82.7738.42-52.18-82.7638.51-52.1616.1422.928.07
20Q2 (6)6634.6953.49-0.5511.29-7.84-1.65-15.38-81.32-1.16-87.117.730.2728.57-37.21-44.51-267.85-1248.79-0.38-18.75-80.95-0.36-16.13-63.64-134.407.76-163.89-134.597.63-164.263.1834.11-3.23
20Q1 (5)4913.9513.95-0.6256.9431.11-1.438.9213.33-0.6282.6831.110.21-22.22-61.82-12.10-63.73-155.15-0.3213.5115.79-0.3149.1818.42-145.7135.06-109.26-145.7135.06-108.75--0.00
19Q4 (4)432.380.0-1.44-97.260.0-1.57-24.60.0-3.58-67.290.00.27-52.630.0-7.39-169.850.0-0.37-32.140.0-0.61-96.770.0-224.37-312.520.0-224.37-312.520.0--0.00
19Q3 (3)42-2.330.0-0.73-43.140.0-1.26-38.460.0-2.14-51.770.00.5732.560.010.58420.610.0-0.28-33.330.0-0.31-40.910.0-54.39-6.790.0-54.39-6.790.0--0.00
19Q2 (2)430.00.0-0.5143.330.0-0.9144.850.0-1.41-56.670.00.43-21.820.0-3.30-115.040.0-0.2144.740.0-0.2242.110.0-50.9326.860.0-50.9327.030.0--0.00
19Q1 (1)430.00.0-0.900.00.0-1.650.00.0-0.900.00.00.550.00.021.940.00.0-0.380.00.0-0.380.00.0-69.630.00.0-69.800.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/30.327.3827.920.8240.940.82N/A-
2024/20.2942.270.860.550.590.81N/A主係保健食品銷量增加
2024/10.21-32.9728.860.2128.860.72N/A-
2023/120.3151.847.642.817.40.970.78-
2023/110.2-54.99-4.272.513.91.050.72-
2023/100.4516.15199.312.34.691.060.7本公司新增保健食品業務,整體收入較同期上升
2023/90.3975.3654.311.85-9.670.791.33本公司新增保健食品業務,整體收入較同期上升
2023/80.2226.68-2.811.46-18.680.512.07-
2023/70.1861.58-40.541.24-21.00.472.25-
2023/60.11-40.38-64.891.06-16.460.482.25本公司機台出貨量較去年同期減少,收入下降
2023/50.18-4.21-30.030.95-0.890.621.74-
2023/40.19-23.1535.050.779.910.611.77-
2023/30.2543.4316.870.583.60.581.86-
2023/20.177.2411.710.33-4.440.541.99-
2023/10.16-23.2-17.280.16-17.280.581.85-
2022/120.21-1.5776.422.62114.230.572.0本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/110.2140.7280.022.41118.30.621.86本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/100.15-40.1191.772.2122.890.631.82本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/90.2510.44108.912.05125.590.781.46本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/80.23-22.5209.851.79128.160.831.36本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/70.3-4.58277.551.57119.690.861.31本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/60.3118.879.01.27100.260.711.35本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/50.2684.89214.680.96108.210.611.57本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/40.14-33.596.930.784.980.511.89本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/30.2137.09171.030.5682.210.561.07本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/20.15-20.5847.610.3551.990.471.28本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/10.1963.7855.650.1955.650.431.39本公司新增動物醫療儀器設備產品,整體收入較同期上升
2021/120.120.43-19.61.2220.510.321.71-
2021/110.1249.9174.691.127.340.321.7本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/100.08-34.7523.650.9919.650.271.97-
2021/90.1263.8131.190.9119.310.271.98本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/80.07-5.56-40.730.7911.050.321.66-
2021/70.08-54.76-25.180.7122.110.331.62-
2021/60.17108.84169.010.6332.410.331.93係受新冠疫情影響,本公司防疫產品銷量增加。
2021/50.0815.7-16.750.4611.280.232.71-
2021/40.07-8.48-32.470.3820.10.252.48-
2021/30.08-25.321.50.3146.630.312.08-
2021/20.1-16.2669.810.2372.780.381.7本期機台出貨量較去年同期增加,收入上升。
2021/10.12-15.475.350.1275.350.322.03本期機台出貨量較去年同期增加,收入上升
2020/120.15243.1681.111.02-44.190.252.87本月機台出貨量較去年同期增加,收入上升
2020/110.04-32.51-58.070.87-50.070.164.59本期機台出貨量較去年同期減少,收入下降
2020/100.0621.97-31.110.82-49.570.243.03-
2020/90.05-58.0-61.920.76-50.680.282.92本期機台出貨量較去年同期減少,收入下降。
2020/80.1219.2-26.50.71-49.580.292.8-
2020/70.162.65-60.00.58-52.750.273.06本期機台出貨量較去年同期減少,收入下降。
2020/60.06-35.37-57.720.48-50.80.273.12本期機台出貨量較去年同期減少,收入下降。
2020/50.1-6.13-16.090.42-49.530.282.98-
2020/40.1137.56-32.220.32-55.150.243.44本期機台出貨累計量較去年同期減少,收入下降。
2020/30.0824.91-38.040.21-61.690.215.05本年累計機台出貨量較去年同期減少,收入下降。
2020/20.06-13.52-73.440.13-68.630.214.94本期機台出貨量較去年同期減少,收入下降。
2020/10.07-12.63-62.80.07-62.80.264.15本期機台出貨量較去年同期減少,收入下降。
2019/120.08-20.57-61.531.82-43.760.283.87本期X光機台出貨量較去年同期減少,收入下降。
2019/110.110.88-70.341.74-42.510.333.22本期X光機台出貨量較去年同期減少,收入下降。
2019/100.09-32.58-59.691.63-38.910.42.68本期機台出貨量較去年同期減少,收入下降。
2019/90.14-18.93-44.451.54-36.960.571.95-
2019/80.17-35.12-52.271.4-36.120.581.91本期X光機台出貨量較去年同期減少,收入下降。
2019/70.2671.93-8.431.24-33.010.532.09-
2019/60.1528.26-29.970.97-37.510.433.38-
2019/50.12-24.18-43.70.82-38.730.0N/A-
2019/40.1625.74-15.130.7-37.80.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)2327.784.490-4.0002.758.2712.96-14.12-0.9301.0301.040
2022 (9)18-75.34-3.770-4.6502.54108.215.090-1.110-0.70-0.670
2021 (8)7317.74-1.300-4.4801.2220.79-6.480-1.030-0.950-0.950
2020 (7)6244.19-1.870-5.8701.01-44.51-23.090-1.340-1.150-1.150
2019 (6)430.0-3.580-5.3901.82-43.658.04-29.9-1.240-1.520-1.520
2018 (5)43-69.72-5.590-10.3903.23-30.3911.47133.6-2.380-2.380-2.380
2017 (4)1420.0-2.930-17.8704.641.314.911.66-4.110-4.150-4.150
2016 (3)142-2.07-3.710-22.0404.58-28.774.83-67.43-5.070-5.260-5.260
2015 (2)14512.4-4.000-25.8706.433.0414.83-19.53-5.950-5.820-5.820
2014 (1)12934.38-4.120-23.3906.2481.9218.430-5.370-5.310-5.320

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。